NaNotics to Collaborate with Mayo Clinic on Nanomedicine Cancer Treatment

NaNotics LLC announced a research collaboration with Mayo Clinic to develop a NaNot that targets the soluble form of PD-L1, a tumor-generated immune inhibitor.